Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
RP Healthcare, Inc. et al v. Pfizer, Inc. et al
Case Number:
3:12-cv-05129
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 05, 2014
Pfizer Nixes Pharmacists' Claims In Lipitor Pay-To-Delay Row
Pfizer Inc. and Ranbaxy Laboratories Inc. on Wednesday beat a member suit brought by a group of nine pharmacists under California law in multidistrict antitrust litigation over Lipitor, with a New Jersey federal judge dismissing the case saying the plaintiffs failed to plausibly show a claim.
-
September 22, 2014
Pfizer Pushes To Ax Rest Of Lipitor Pay-For-Delay Suit
Pfizer Inc. and Ranbaxy Laboratories Ltd. urged a New Jersey federal judge on Friday to toss indirect purchasers' antitrust suit in multidistrict litigation challenging a purportedly anti-competitive patent infringement settlement between the companies over Lipitor, saying the claims were doomed after a similar direct purchaser action was recently dismissed.